Vericel (VCEL) Common Equity (2010 - 2026)

Vericel has disclosed Common Equity across 17 years of filings, most recently posting $356.2 million for Q1 2026.

• Common Equity for Q1 2026 came in at $356.2 million, up 20.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $356.2 million (up 20.56% YoY), and the FY2025 annual result was $354.6 million, up 21.47% from the prior year.
• Common Equity came in at $356.2 million for Q1 2026 at Vericel, roughly flat from $354.6 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $356.2 million in Q1 2026 to a low of $172.5 million in Q1 2022.
• The 5-year median for Common Equity is $233.9 million (2024), against an average of $247.2 million.
• Across the five-year window, Common Equity advanced 12.46% in 2023 and advanced 29.22% in 2024, its largest moves.
• Vericel's Common Equity stood at $192.3 million in 2022, then gained by 17.52% to $226.0 million in 2023, then increased by 29.22% to $292.0 million in 2024, then grew by 21.47% to $354.6 million in 2025, then increased by 0.45% to $356.2 million in 2026.
• The last three Common Equity figures came in at $356.2 million (Q1 2026), $354.6 million (Q4 2025), and $321.9 million (Q3 2025), per Business Quant data.